Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
From MaRDI portal
Publication:5280185
Recommendations
- Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
- Identification of longitudinal biomarkers in survival analysis for competing risks data
- Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker
- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- The identification of potential longitudinal biomarkers and measurements of effectiveness for biomarkers as surrogates in multivariate survival data
- Buckley-James boosting for survival analysis with high-dimensional biomarker data
- Identification of potential longitudinal biomarkers under the accelerated failure time model in multivariate survival data
- Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome
- Identification of longitudinal biomarkers for survival by a score test derived from a joint model of longitudinal and competing risks data
Cites work
- scientific article; zbMATH DE number 720689 (Why is no real title available?)
- scientific article; zbMATH DE number 845714 (Why is no real title available?)
- scientific article; zbMATH DE number 6123298 (Why is no real title available?)
- scientific article; zbMATH DE number 3385132 (Why is no real title available?)
- A lasso for hierarchical interactions
- A significance test for the lasso
- A simple method for estimating interactions between a treatment and a large number of covariates
- Adaptive Lasso for Cox's proportional hazards model
- Boosting With theL2Loss
- Greedy function approximation: A gradient boosting machine.
- Model Selection and Estimation in Regression with Grouped Variables
- Operating Characteristics and Extensions of the False Discovery Rate Procedure
- Regularization and Variable Selection Via the Elastic Net
- Ridge Regression: Biased Estimation for Nonorthogonal Problems
- The Adaptive Lasso and Its Oracle Properties
Cited in
(11)- Identifying optimal biomarker combinations for treatment selection via a robust kernel method
- Ranked sparsity: a cogent regularization framework for selecting and estimating feature interactions and polynomials
- Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
- Two-step hypothesis testing to detect gene-environment interactions in a genome-wide scan with a survival endpoint
- A Scalable Hierarchical Lasso for Gene–Environment Interactions
- Efficient screening of predictive biomarkers for individual treatment selection
- A simulation study comparing different statistical approaches for the identification of predictive biomarkers
- A three-stage approach to identify biomarker signatures for cancer genetic data with survival endpoints
- Oblique random survival forests
- IPF-LASSO: integrative \(L_1\)-penalized regression with penalty factors for prediction based on multi-omics data
- Sparse classification with paired covariates
This page was built for publication: Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5280185)
